Oxford-AstraZeneca’s Oxford-Vaxzevria COVID-19 vaccine, Covishield in India, is being challenged in London High Court. Test cases of Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT), thought to be related to the COVID jab’s side effects, could lead to more claims…
On Thursday, UK media reported that the Oxford-AstraZeneca COVID-19 vaccine, Vaxzevria in Europe and Covishield in India, is being challenged in the High Court in London. According to a news agency, UK-based pharmaceutical giant AstraZeneca may face more claims based on test cases of Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT), believed to be linked to the COVID jab.
AstraZeneca said regulators worldwide “consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects” and patient safety is its “highest priority”.
“The fact of this legal battle poses a fundamental question: in circumstances where individuals are seriously injured or die because of a vaccination recommended by the government – should the state provide adequate compensation, or should the bereaved and injured be required to fight for compensation in the courts against the vaccine producer?” says Sarah Moore, a partner at Hausfeld, which is bringing the case for the COVID vaccine class.
Anish Tailor, of Indian descent, is suing for damages after his wife, 35-year-old Alpa Tailor, died a month after receiving the vaccine. Blood clots and brain bleeding from VITT killed her, according to a September 2021 inquiry.
Jamie Scott, a father-of-two who suffered brain injury after receiving the jab in April 2021, is bringing the test claim alongside the “Vaccine Injured and Bereaved vs AstraZeneca – VITT Litigation” CrowdJustice group, which has raised over GBP 8,000 of its GBP 10,000 target for its legal “fighting fund”.
AstraZeneca said, “We do not comment on ongoing litigation matters. Patient safety is our primary priority, and regulatory bodies set tight requirements for all drugs, including immunizations. We sympathize with people who have lost loved ones or suffer illness. From the body of evidence in clinical trials and real-world data, Vaxzevria has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.”
The company also claimed that it has provided 3 billion doses of the vaccine to 180 nations and saved 6 million lives in an independent study.
A UK-based Indian-origin consultant cardiologist who has advocated for COVID vaccination inspection encouraged the Indian government to investigate.
“After publishing research last year making the case for the suspension of the COVID mRNA vaccine over its safety, I was shocked to learn that as far as cardiovascular effects were concerned, the Covishield vaccine was even worse for its short-term cardiovascular harms,” said Dr Malhotra.
“After this historic case on AstraZeneca’s vaccination in the UK, I believe neither vaccine should have been given to a single person without informed consent. He requested an investigation from Prime Minister Narendra Modi.
Conclusion
The Oxford-AstraZeneca COVID-19 vaccine, Covishield in India, is being challenged in the London High Court. The vaccine allegedly caused major injury and death in some people.
AstraZeneca claims their vaccine is safe based on clinical trials and real-world data. It also claims to have distributed 3 billion doses of the vaccine to 180 countries and saved 6 million lives in an independent study.
Jamie Scott, a father of two who was brain-injured following the April 2021 jab, is suing. Scott is part of the CrowdJustice organization “Vaccine Injured and Bereaved vs AstraZeneca – VITT Litigation” that has generated over GBP 8,000 of its GBP 10,000 target for its legal “fighting fund”.
Dr. Aseem Malhotra, a UK-based Indian consultant cardiologist, wants the Indian government to investigate the Covishield vaccine’s safety. Dr. Malhotra has released evidence supporting the COVID mRNA vaccination suspension due to safety concerns. He calls the Covishield vaccination “even worse for its short-term cardiovascular harms”.
The UK legal challenge may affect India’s Covishield vaccination use. The Indian government should carefully analyze judicial evidence and take steps to protect residents’ health.
